​

Funding Round

Series A - Reprieve Cardiovascular

Series A - Reprieve Cardiovascular

Investment Firm

Overview

Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.

Announced Date

Feb 20, 2024

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Sante Ventures

Sante Ventures

Sante Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed firm.

Lightstone Ventures

Lightstone Ventures

Lightstone Ventures is a early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

5

Investor Name
Participant InvestorGenesis Capital
Participant InvestorDeerfield Management
Participant InvestorLightstone Ventures
Participant InvestorSante Ventures
Participant InvestorArboretum Ventures

Round Details and Background

Reprieve Cardiovascular raised $42000000 on 2024-02-20 in Series A

Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 04, 2020
Series A - Reprieve Cardiovascular
1-15.0M
Jun 07, 2022
Venture Round - Reprieve Cardiovascular
-15.0M
Nov 17, 2023
Venture Round - Reprieve Cardiovascular
-12.1M
Feb 20, 2024
Series A - Reprieve Cardiovascular
5-42.0M

Recent Activity

There is no recent news or activity for this profile.